1. Wils J. The treatment of advanced gastric cancer.Semin Oncol 1996;23(3): 397–406.
2. Glimelius B, Hoffman K, Haglund U. Initial or delayed chemotherapy with best supportive care in advanced gastric cancer.Ann Oncol 1994;5: 189–190.
3. Pyrhonen S, Kuitumen T, Kouri M. A randomized phase III triel comparing fluorouracil, epidoxorubicin and methotrexate (FEMTX) with best supportive care in non resectable gastric cancer (Abstract).Ann Oncol 1992;3(2): 12.
4. Nissen NI, Larsen V, Pedersen H, Thomsen K. Phase I clinical trial of a new anti-tumor agent NSC 141540, VP16-213.Cancer Chemother Rep 1972;56(6): 769–777.
5. Eagan RT, Carr DT, Frytak S, Rubin J, Lee RE. VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer.Cancer Treat Rep 1972;60: 949–951.